Señales en vivo de RAINBOW.NS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 may 2024 @ 03:00):

Stats
Volumen de hoy	44 343.00
Volumen promedio	333 610
Capitalización de mercado	141.49B
EPS	INR6.20 ( 2023-10-30 )
Last Dividend	INR3.00 ( 2023-06-22 )
Next Dividend	INR0 ( N/A )
P/E	64.12
ATR14	INR2.30 (0.17%)

Volumen Correlación

Largo: 0.19 (neutral)

Corto: 0.37 (neutral)

Signal:(50.557) Neutral

Rainbow Children's Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Rainbow Children's Correlación - Moneda/Commodity

0.44
( neutral )

0.40
( neutral )

0.42
( neutral )

0.24
( neutral )

0.49
( neutral )

-0.35
( neutral )

Rainbow Children's Finanzas

Annual	2022
Ingresos:	INR11.74B
Beneficio Bruto:	INR10.15B (86.51 %)
EPS:	INR20.89

FY	2022
Ingresos:	INR11.74B
Beneficio Bruto:	INR10.15B (86.51 %)
EPS:	INR20.89

FY	2022
Ingresos:	INR9.74B
Beneficio Bruto:	INR7.79B (80.00 %)
EPS:	INR13.62

FY	2021
Ingresos:	INR6.40B
Beneficio Bruto:	INR5.37B (83.86 %)
EPS:	INR3.90

Financial Reports:

No articles found.

Rainbow Children's Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR2.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Rainbow Children's Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.46 - low (48.13%) | Divividend Growth Potential Score: 5.21 - Stable (4.13%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR2.00	2022-09-07
Last Dividend	INR3.00	2023-06-22
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	INR5.00	--
Avg. Dividend % Per Year	0.21%	--
Score	2.05	--
Div. Sustainability Score	4.46
Div.Growth Potential Score	5.21
Div. Directional Score	4.83	--

Next Divdend (Est)
(2024-09-30)

INR3.67 Estimate 3.00 %

Dividend Stability

0.24 Very Poor

Dividend Score

2.05

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2022	INR2.00	0.44%
2023	INR3.00	0.40%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SMCGLOBAL.NS	Dividend Knight	2023-06-16	Semi-Annually	4	1.29%
METROBRAND.NS	Dividend Junior	2023-08-31	Semi-Annually	3	0.18%
GTPL.NS	Dividend Knight	2023-09-22	Annually	8	1.73%
BANDHANBNK.NS	Dividend Junior	2023-08-11	Sporadic	7	0.20%
PSPPROJECT.NS	Dividend Junior	2023-09-01	Annually	8	0.49%
KANSAINER.NS	Dividend Knight	2023-05-25	Annually	21	0.49%
DTIL.NS	Dividend Junior	2023-09-12	Annually	10	0.98%
ACC.NS	Dividend Junior	2023-07-06	Annually	22	0.86%
SUNPHARMA.NS	Dividend Knight	2023-07-28	Semi-Annually	29	0.77%
NATCOPHARM.NS	Dividend Junior	2023-08-22	Semi-Annually	29	0.68%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.173	1.500	6.55	9.82	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.199	1.500	8.90	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6.12	1.000	8.85	8.85	[3 - 30]
operatingCashFlowPerShareTTM	20.20	2.00	3.27	6.53	[0 - 30]
freeCashFlowPerShareTTM	20.20	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.870	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.270	1.000	6.59	6.59	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.46

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	64.42	1.000	3.59	0	[1 - 100]
returnOnEquityTTM	0.199	2.50	9.29	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	20.20	2.00	3.27	10.00	[0 - 30]
dividendYielPercentageTTM	0.215	1.500	4.62	0	[0 - 0.4]
operatingCashFlowPerShareTTM	20.20	2.00	3.27	6.53	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	2.69	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.161	1.000	8.47	0	[0.1 - 0.5]
Total Score				5.21

Rainbow Children's Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Rainbow Children's

Rainbow Children's Medicare Limited operates a multi-specialty pediatric and obstetrics, and gynecology hospital chain in India. The company's child health services include general pediatrics, neonatalogy, surgery, gastroenterology and liver diseases, hematology and oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, psychiatry, ENT, cardiology, radiology, physiotherapy and rehabilitation, orthopedics, urology, ophthalmology, dermatology, allergy, neurosurgery, rheumatology, infectious disease, and cranio-maxillofacial surgery; intensive care unit, bone marrow transplant unit, anesthesia and pain management, kidney transplant, cochlear implant services; genetics and metabolic medicines; and laboratory, speech and language therapy, occupational therapy, pediatric and metabolic medicine, developmental and behavioral pediatrics, cerebral palsy care services. Its women health services include obstetrics and gynecology, painless delivery and labor, high risk pregnancy, pregnancy and delivery, childbirth preparation classes, vaginal birth after cesarean, breast feeding support, well women checkup, urogynecology, pre-pregnancy health checkup, minimally invasive surgery, breast care, fetal medicine, menopausal treatment, new-born care, women's nutrition, and diabetology. The company also provides fertility care services, such as fertility treatment, ovulation induction, intracytoplasmic sperm injection treatment, investigation, intrauterine insemination, intracytoplasmic morphologically selected sperm injection, assisted hatching, cryopreservation, sperm and oocyte donor treatments, frozen embryo transfer, surgical sperm retrieval, embryo donor treatments, reproductive surgery, pre-conception counselling, and andrology and urology. As of December 31, 2021, it operated 14 hospitals and 3 clinics in 6 cities with a total of 1,500 beds. The company was incorporated in 1998 and is based in Hyderabad, India.